1. OUP accepted manuscript
- Author
-
Yongping Fan, Hongzhu Guo, Qi Zheng, Yiyi Zhao, Lei Wang, Hui Zhao, Tao Yang, Haiyan Zou, and Haolong Liu
- Subjects
chemistry.chemical_compound ,Chromatography ,chemistry ,Uplc qtof ms ,law ,General Medicine ,Phenylethanoid ,Mass spectrometry ,Orbitrap ,High-performance liquid chromatography ,Analytical Chemistry ,law.invention - Abstract
Traditional Chinese medicines (TCMs) have been considered as important alternative therapeutics because of their significant medicinal benefits in specific diseases. Chinese herb formula is characterized by a vast molecule that differs in routine medicines. Due to TCMs chemical complexity, proper quality control has been a great challenge. Choosing the appropriate method to identify and qualify these compounds is an important work to ensure its safety, efficacy and quality control. Thus, this study aimed at providing novel information on high-resolution LTQ-Orbitrap mass spectrometer (UPLC-LTQ-Orbitrap-MSn) based identification of Bu Shen Yi Sui capsule (BSYSC), which is used in treating multiple sclerosis as a kind of TCMs. Under the proposed chromatographic conditions, 80 chemical components classified as anthraquinone, phenolic acid and phenylethanoid glycosides were separated and identified from BSYSC. Coupled with the high-performance liquid chromatography quadrupole time-of-flight mass spectrometry (UPLC-QTOF-MS/MS) method, eight of them were regarded as marker compounds for the quantitative evaluation of BSYSC. The identification and quantification with precision of UPLC-LTQ-Orbitrap-MSn and UPLC-QTOF-MS/MS could facilitate essential data for further pharmacokinetic studies of BSYSC.
- Published
- 2021
- Full Text
- View/download PDF